spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

LogiMed 2017

Logi_Med_2017

18-19 October 2017
Hyperion Hotel, Hamburg

Taking place 18-19th October in Hamburg, LogiMed is Europe’s only dedicated medical device supply chain event bringing together over 150 Medical Device Supply Chain Professionals to network with. With a greater focus on customer collaboration and digital transformation this year’s LogiMed delivers real insights on inventory visibility, supply chain planning, global logistics and digitalization.

Over 2 inspiring days, learn from best-in-class case studies, engage in thought-provoking debates and share your pain points in small, interactive peer-to-peer working groups.

Download the latest agenda now

PMPS is a proud partner of LogiMed 2017 and is pleased to offer you a 15% discount off the full ticket price to attend. Use the code PMPS15 when you register online here.

Follow us:
LinkedIn
Twitter
phone 44 (0) 207 368 9766
web bit.ly/2tEaxqD
email Hyperion Hotel, Hamburg
 
Print this page
Send to a friend
   
spacer
Industry Events

8th Clinical Quality Oversight Forum 2017

11-13 October 2017, Sheraton Philadelphia Downtown Hotel, Philadelphia, PA

ExL’s Clinical Quality Oversight Forum continues to live up to its reputation as an elite gathering of senior-level executives.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>


News and Press Releases

New research confirms correlation of common bacteria (including MRSA) and eczema


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement